Photoelectron spectroscopy : chemical and analytical aspects / by 209077 Baker, Arthur D., Betteridge, D.

Modern analytical methods / by 387365 Betteridge, D., Hallam, H. E.

Status report of lipid-lowering trials in diabetes. by Betteridge, D, Colhoun, H, Armitage, J

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study. by Neil, H, Hawkins, M, Durrington, P, Betteridge, D, Capps, N, Humphries, SE

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study. by Neil, H, Huxley, R, Hawkins, M, Durrington, P, Betteridge, D, Humphries, SE

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Thomason, M, Fuller, J

Effect of atorvastatin on stroke in the collaborative atorvastatin diabetes study (CARDS): Factors predictive of the risk of stroke by Newman, C, Szarek, M, Hitman, G, Colhoun, H, Betteridge, D, Durrington, P, Neil, H, Livingstone, S, Fuller, J

Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. by Thomason, M, Colhoun, H, Livingstone, S, Mackness, M, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Fuller, J

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. by Colhoun, H, Thomason, M, Mackness, M, Maton, S, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Fuller, J

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). by Hitman, G, Colhoun, H, Newman, C, Szarek, M, Betteridge, D, Durrington, P, Fuller, J, Livingstone, S, Neil, H

Effect of atorvastatin in patients 65 years of age with type 2 diabetes: Subgroup analysis from the collaborative atorvastatin diabetes study (CARDS) by DeMicco, D, Luo, D, Betteridge, D, Colhoun, H, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Fuller, J

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). by Neil, H, DeMicco, D, Luo, D, Betteridge, D, Colhoun, H, Durrington, P, Livingstone, S, Fuller, J, Hitman, G

Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS) by Newman, C, Szarek, M, Demicco, D, Hitman, G, Colhoun, H, Betteridge, D, Durrington, P, Neil, H, Livingston, S, Fuller, J

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS). by Newman, C, Szarek, M, Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Demicco, D, Auster, S, Fuller, J

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study. by Neil, H, Cooper, J, Betteridge, D, Capps, N, McDowell, I, Durrington, P, Seed, M, Mann, J, Humphries, SE

Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Charlton-Menys, V, DeMicco, D, Fuller, J

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. by Soedamah-Muthu, S, Colhoun, H, Thomason, M, Betteridge, D, Durrington, P, Hitman, G, Fuller, J, Julier, K, Mackness, M, Neil, H

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlle... by Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Thomason, M, Mackness, M, Charlton-Menys, V, Fuller, J

Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. by Betteridge, D, Bhatnager, D, Bing, R, Durrington, P, Evans, G, Flax, H, Jay, R, Lewis-Barned, N, Mann, J, Matthews, DR

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS). by Raikou, M, McGuire, A, Colhoun, H, Betteridge, D, Durrington, P, Hitman, G, Neil, H, Livingstone, S, Charlton-Menys, V, Fuller, J